Effects of Indacaterol in Symptomatic COPD Patients With Low Risk of Exacerbations

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 28, 2015

Primary Completion Date

April 19, 2016

Study Completion Date

April 19, 2016

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG

Indacaterol

Indacaterol 150µg capsules for inhalation daily

DRUG

Placebo

Matching placebo indacaterol capsules for inhalation daily

Trial Locations (1)

Novartis Investigative Site, Hong Kong